Landscape of short‐acting beta‐agonists (SABA) overuse in Europe
L de Las Vecillas, S Quirce - Clinical & Experimental Allergy, 2023 - Wiley Online Library
This review article provides an overview of short‐acting beta‐agonist (SABA) use and
prescribing trends in Europe, summarizing updated data on the results from the industry …
prescribing trends in Europe, summarizing updated data on the results from the industry …
Over-the-counter use of short-acting beta-2 agonists: a systematic review
ZC Loh, R Hussain, SC Ong, B Saini… - … of Pharmaceutical Policy …, 2023 - Springer
Background The widespread use of short-acting beta-2 agonists (SABA) as an as-needed
treatment for asthma is well-established. However, excessive use of SABA has been linked …
treatment for asthma is well-established. However, excessive use of SABA has been linked …
[HTML][HTML] Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia
HC Wang, S Djajalaksana, L Sharma… - World Allergy …, 2023 - Elsevier
Background The extent of short-acting Beta-2-agonist (β 2-agonist)(SABA) use across Asian
countries is not well documented. As part of the SABA use IN Asthma (SABINA) III study, we …
countries is not well documented. As part of the SABA use IN Asthma (SABINA) III study, we …
Expert consensus on SABA use for asthma clinical decision-making: a Delphi approach
N Lugogo, M O'Connor, M George, R Merchant… - Current allergy and …, 2023 - Springer
Purpose of Review A modified Delphi process was undertaken to provide a US expert-led
consensus to guide clinical action on short-acting beta2-agonist (SABA) use. This comprised …
consensus to guide clinical action on short-acting beta2-agonist (SABA) use. This comprised …
Gaps in asthma diagnosis and treatment in low-and middle-income countries
M Barne - Frontiers in Allergy, 2023 - frontiersin.org
Low-and middle-income countries (LMICs) contribute to a major proportion of asthma
morbidity and mortality globally, even though the prevalence is higher in high income …
morbidity and mortality globally, even though the prevalence is higher in high income …
Toward a better understanding of severe asthma phenotypes in Latin America: results from the PREPARE study
J Maspero, J Pavie, CA Torres-Duque… - Current Medical …, 2023 - Taylor & Francis
Objective Data on severe asthma phenotypes in Latin America are lacking. The PREPARE
study describes the prevalence of certain determinants of severe asthma among patients in …
study describes the prevalence of certain determinants of severe asthma among patients in …
SABAs as reliever medications in asthma management: evidence-based science
I Amirav, G Garcia, BK Le, P Barria, G Levy… - Advances in …, 2023 - Springer
The role of as-needed inhaled short-acting β2-agonists (SABAs) in the management of
asthma has become a subject of debate due to differing opinions in the professional …
asthma has become a subject of debate due to differing opinions in the professional …
Short-acting β2-agonists over-prescription in patients with asthma: an Indian subset analysis of international SABINA III study
M Modi, K Mody, P Jhawar, L Sharma… - Journal of …, 2023 - Taylor & Francis
Abstract Objective The SABINA (SABA use IN Asthma) program was initiated to describe
short-acting β2-agonists (SABA) prescription patterns and assess the impact of its over …
short-acting β2-agonists (SABA) prescription patterns and assess the impact of its over …
Overprescription of short‐acting β2‐agonists among patients with asthma in Saudi Arabia: Results from the SABINA III cohort study
H Al‐Jahdali, S Wali, AS Albanna… - The Clinical …, 2022 - Wiley Online Library
Despite near‐universal health care and timely updates to treatment guidelines in Saudi
Arabia, asthma control remains suboptimal, warranting deeper exploration of its …
Arabia, asthma control remains suboptimal, warranting deeper exploration of its …
[HTML][HTML] The use of systemic corticosteroids in asthma management in Latin American countries
The stepwise treatment approach recommended by the Global Initiative for Asthma (GINA)
includes systemic corticosteroids (SCS) suggested as a final step if asthma is severe and/or …
includes systemic corticosteroids (SCS) suggested as a final step if asthma is severe and/or …